Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2020-09-24
2021-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EnergieShake® Acceptability and Tolerance Study
NCT02788032
EnergieShake 1.5kcal Complete Acceptability and Tolerance Study
NCT02796482
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
NCT06298292
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
NCT07341464
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
NCT06046820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EnergieShake® Junior Powder Complete (test)
EnergieShake® Junior Powder Complete will be consumed by children, as a supplement to normal diet, over a period of 7 day period to determine its acceptability (liking, compliance) and tolerance (gastro-intestinal tolerance). The dose will be the same as currently consumed product (all children recruited to the study will be consuming an oral nutritional supplement).
EnergieShake® Junior Powder Complete
Oral Nutritional Supplement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EnergieShake® Junior Powder Complete
Oral Nutritional Supplement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children currently prescribed and consuming Oral Nutritional Supplements (ONS)
* Willingness to take part in the study, and consent to the study protocol signed by parent/guardian or older child (when appropriate)
Exclusion Criteria
* Participants on parenteral nutrition
* Participants with cow's milk or soy allergy or lactose intolerance
* Participants with galactosaemia
* Participants with a chronic renal or liver disease
* Participants who are acutely unwell
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brighton and Sussex University Hospitals NHS Trust
OTHER
Great Ormond Street Hospital for Children NHS Foundation Trust
OTHER
The Leeds Teaching Hospitals NHS Trust
OTHER
Anaiah Healthcare Pvt Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brighton & Sussex NHS Trust
Brighton, , United Kingdom
Leeds Children's Hospital,
Leeds, , United Kingdom
Great Ormond Street Hospital Foundation Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chris Smith
Role: primary
Jacqueline Lowdon
Role: primary
Graeme O'Connor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESj-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.